The influence of c-Myc on the expression of glutamate dehydrogenase and glutamate-dependent transaminases has been reported by various independent groups aiming to characterize c-Myc-driven metabolic reprogramming in different tumor types. This evidence concerns the gene MYC and neoplasm.